|
|
||||||||
From the Departments of Pediatrics (Drs. Juhász, Nagy, da Silva, D.C. Chugani, and H.T. Chugani), Neurology (Drs. Watson, Shah, and H.T. Chugani), and Radiology (Drs. Muzik, D.C. Chugani, and H.T. Chugani), Childrens Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI.
Address correspondence and reprint requests to Dr. H.T. Chugani, Childrens Hospital of Michigan PET Center, 3901 Beaubien Boulevard, Detroit, MI 48201.
OBJECTIVES: To analyze interictal patterns of thalamic nuclei glucose metabolism and benzodiazepine receptor binding in patients with medically intractable temporal lobe epilepsy (TLE) using high-resolution 2-deoxy-2-[18F]fluoro-D-glucose (FDG) and [11C]flumazenil (FMZ) PET.
BACKGROUND: Structural and glucose metabolic abnormalities of the thalamus are considered important in the pathophysiology of TLE. The differential involvement of various thalamic nuclei in humans is not known.
METHODS: Twelve patients with TLE underwent volumetric MRI, FDG and FMZ PET, and prolonged video-EEG monitoring. Normalized values and asymmetries of glucose metabolism and FMZ binding were obtained in three thalamic regions (dorsomedial nucleus [DMN], pulvinar, and lateral thalamus [LAT]) defined on MRI and copied to coregistered, partialvolume-corrected FDG and FMZ PET images. Hippocampal and amygdaloid FMZ binding asymmetries and thalamic volumes also were measured.
RESULTS: The DMN showed significantly lower glucose metabolism and FMZ binding on the side of the epileptic focus. The LAT showed bilateral hypermetabolism and increased FMZ binding. There was a significant correlation between the FMZ binding asymmetries of the DMN and amygdala. The PET abnormalities were associated with a significant volume loss of the thalamus ipsilateral to the seizure focus.
CONCLUSIONS: Decreased [11C]flumazenil (FMZ) binding and glucose metabolism of the dorsomedial nucleus (DMN) are common and have strong lateralization value for the seizure focus in human temporal lobe epilepsy. Decreased benzodiazepine receptor binding can be due to neuronal loss, as suggested by volume loss, but also may indicate impaired
-aminobutyric acid (GABA)ergic transmission in the DMN, which has strong reciprocal connections with other parts of the limbic system. Increased glucose metabolism and FMZ binding in the lateral thalamus could represent an upregulation of GABA-mediated inhibitory circuits.
Key words: EpilepsyPETThalamusGlucose metabolismFlumazenilVolumetry.
This article has been cited by other articles:
![]() |
K.K. Lee and N. Salamon [18F] Fluorodeoxyglucose-Positron-Emission Tomography and MR Imaging Coregistration for Presurgical Evaluation of Medically Refractory Epilepsy AJNR Am. J. Neuroradiol., November 1, 2009; 30(10): 1811 - 1816. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rajasekaran, J. Kapur, and E. H. Bertram Alterations in GABAA Receptor Mediated Inhibition in Adjacent Dorsal Midline Thalamic Nuclei in a Rat Model of Chronic Limbic Epilepsy J Neurophysiol, November 1, 2007; 98(5): 2501 - 2508. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Lin, M. A. K. de Aburto, M. Dahlbom, L. L. Huang, M. M. Marvi, M. Tang, J. Czernin, M. E. Phelps, and D. H.S. Silverman Predicting Seizure-Free Status for Temporal Lobe Epilepsy Patients Undergoing Surgery: Prognostic Value of Quantifying Maximal Metabolic Asymmetry Extending over a Specified Proportion of the Temporal Lobe J. Nucl. Med., May 1, 2007; 48(5): 776 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guye, J. Regis, M. Tamura, F. Wendling, A. M. Gonigal, P. Chauvel, and F. Bartolomei The role of corticothalamic coupling in human temporal lobe epilepsy Brain, July 1, 2006; 129(7): 1917 - 1928. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Y. Joo, S. B. Hong, H. J. Han, W. S. Tae, J. H. Kim, S. J. Han, D. W. Seo, K.-H. Lee, S.-C. Hong, M. Lee, et al. Postoperative alteration of cerebral glucose metabolism in mesial temporal lobe epilepsy Brain, August 1, 2005; 128(8): 1802 - 1810. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Maxwell, K. Pennington, M. A. MacKinnon, D. H. Smith, T. K. McIntosh, J. T. L. Wilson, and D. I. Graham Differential responses in three thalamic nuclei in moderately disabled, severely disabled and vegetative patients after blunt head injury Brain, November 1, 2004; 127(11): 2470 - 2478. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Gartner, M Seeck, C M Michel, J Delavelle, and F Lazeyras Patients with extratemporal lobe epilepsy do not differ from healthy subjects with respect to subcortical volumes J. Neurol. Neurosurg. Psychiatry, April 1, 2004; 75(4): 588 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. X. Zhang and E. H. Bertram Different Reactions of Control and Epileptic Rats to Administration of APV or Muscimol on Thalamic or CA3-Induced CA1 Responses J Neurophysiol, November 1, 2003; 90(5): 2875 - 2883. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sojkova, P. J. Lewis, A. H. Siegel, A. M. Siegel, D. W. Roberts, V. M. Thadani, and P. D. Williamson Does Asymmetric Basal Ganglia or Thalamic Activation Aid in Seizure Foci Lateralization on Ictal SPECT Studies? J. Nucl. Med., September 1, 2003; 44(9): 1379 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Natsume, N. Bernasconi, F. Andermann, and A. Bernasconi MRI volumetry of the thalamus in temporal, extratemporal, and idiopathic generalized epilepsy Neurology, April 22, 2003; 60(8): 1296 - 1300. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Lee, K. J. Meador, Y. D. Park, D. W. King, A. M. Murro, J. J. Pillai, and R. J. Kaminski Pathophysiology of altered consciousness during seizures: Subtraction SPECT study Neurology, September 24, 2002; 59(6): 841 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Van Laere, K. Vonck, P. Boon, J. Versijpt, and R. Dierckx Perfusion SPECT Changes After Acute and Chronic Vagus Nerve Stimulation in Relation to Prestimulus Condition and Long-Term Clinical Efficacy J. Nucl. Med., June 1, 2002; 43(6): 733 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. X. Zhang and E. H. Bertram Midline Thalamic Region: Widespread Excitatory Input to the Entorhinal Cortex and Amygdala J. Neurosci., April 15, 2002; 22(8): 3277 - 3284. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dreifuss, F. J.G. Vingerhoets, F. Lazeyras, S. Gonzales Andino, L. Spinelli, J. Delavelle, and M. Seeck Volumetric measurements of subcortical nuclei in patients with temporal lobe epilepsy Neurology, November 13, 2001; 57(9): 1636 - 1641. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Juhasz, D. C. Chugani, O. Muzik, A. Shah, J. Shah, C. Watson, A. Canady, and H. T. Chugani Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome Neurology, June 26, 2001; 56(12): 1650 - 1658. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hammers, M.J. Koepp, C. Labbe, D.J. Brooks, M. Thom, V.J. Cunningham, and J.S. Duncan Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy Neurology, April 10, 2001; 56(7): 897 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Juhasz, D. C. Chugani, O. Muzik, C. Watson, J. Shah, A. Shah, and H. T. Chugani Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy Neurology, September 26, 2000; 55(6): 825 - 835. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |